title: Inherited long QT syndrome: phenotype and therapy to use and avoid.
abstract: Patients with long QT syndrome are most commonly of three types. It is important to understand several points about this potentially lethal syndrome: 1. What precipitates the syndrome? 2. What channelopathies are involved? 3. What are the characteristic T-wave abnormalities seen in patients with long QT syndrome? 4. What therapy should be initiated? 5. Who needs an ICD? Table I summarizes several key features of the different long QT syndromes.
authors.forename: C Richard
authors.initials: CR
authors.lastname: Conti
mesh_terms: D000083:Acetanilides; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000075202:Contraindications; D017147:Defibrillators, Implantable; D004358:Drug Therapy; D006801:Humans; D008133:Long QT Syndrome / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D010641:Phenotype; D010879:Piperazines / Q000627:therapeutic use; D000069458:Ranolazine
chemical_list: D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D010879:Piperazines; D000069458:Ranolazine